Delivery Order SPE2DB20D3103-SPE2DB25FQ4G2
- Not listed
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This firm fixed-price delivery order, valued at $13,846.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Vyndamax 61 mg capsule unit dose in quantities of 30, with a firm fixed price ceiling value of $41,540.91 and an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract represents a direct purchase under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) with a ceiling value of $55,387.88. This is a firm fixed price delivery order with an ultimate completion date of June 24, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location....
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, which is not set-aside and carries a firm fixed price structure, is scheduled for ultimate completion by July 14, 2025. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a firm fixed price structure. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (unit dose, 30-count packages) on September 26, 2025, with completion targeted for October 20, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on September 18, 2025, with completion scheduled for October 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4G2Delivery Order
The Defense Logistics Agency awarded a $55,387.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract, which represents a non-competitive set-aside award, is scheduled for completion by October 14, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated capability to fulfill federal requirements through competitive procurement processes. The company's extensive portfolio with the Defense Logistics Agency encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies across multiple therapeutic domains. This award for Vyndamax—a medication used in the treatment of transthyretin amyloidosis—reflects the contractor's role in supporting Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles designed to ensure pharmaceutical availability for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.4k | 9/22/25 |